Global Genomics Biomarkers Market 2017-2021

NEW YORK, March 13, 2017 /PRNewswire/ -- Genomics Biomarkers

A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).

Technavio's analysts forecast the global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global genomics biomarkers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomic biomarkers.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Genomics Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Roche Diagnostics
- Myriad Genetics
- QIAGEN
- Thermo Fisher Scientific
- Bio-Rad Laboratories


Read the full report: http://www.reportlinker.com/p04647369-summary/view-report.html


Other prominent vendors
- 23andMe
- Aepodia
- Almac Group
- AROS Applied Biotechnology
- DNAVision
- Epigenomics
- Epistem
- Eurofins Scientific
- Foundation Medicine
- Genomic Health
- Liquid Genomics
- New England Biolabs
- OriGene
- US Biomarkers

Market driver
- Genomics biomarker-based personalized medicine
- For a full, detailed list, view our report

Market challenge
- Delay in time from lab to market
- For a full, detailed list, view our report

Market trend
- Expansion of new business models
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.



Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Read the full report: http://www.reportlinker.com/p04647369-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-genomics-biomarkers-market-2017-2021-300422908.html

SOURCE Reportlinker